This pathway is physiologically responsible of the normal development of the embryo, but in patients with Gorlin-Goltz syndrome PTCH mutations cause uncontrolled signaling through SMO, with high rates of cancer, especially BCCs [7]. This evidence concerns the gene PTCH1 and cancer.